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We examined whether maternal exposure to food antigens during lactation and maternal allergic status would aﬀect the
development of food allergy in oﬀspring. OVA-sensitized or OVA-nonsensitized BALB/c female mice were exposed or unexposed
to OVA during lactation. After weaning, their oﬀspring were systemically sensitized twice with OVA and repeatedly given OVA
by oral intubation. While 97.1% of the mice breastfed by OVA-nonsensitized and OVA-unexposed mothers developed allergic
diarrhea, 59.7% of the mice breastfed by OVA-exposed nonallergic mothers during lactation and 24.6% of the mice breastfed by
OVA-exposed allergic mothers during lactation developed food allergy. Furthermore, OVA was detected in breast-milk from OVA-
exposed nonallergic mothers during lactation (4.6 ± 0.5μg/mL). In addition, OVA-speciﬁc IgG1 titers were markedly increased
in breast milk from allergic mothers (OVA-sensitized and OVA-unexposed mother: 11.0 ± 0.5, OVA-sensitized and OVA-exposed
mother: 12.3±0.3). Our results suggest that oral tolerance induced by breast milk-mediated transfer of dietary antigens along with
their speciﬁc immunoglobulins to oﬀspring leads to antigen-speciﬁc protection from food allergy.
1.Introduction
Over the last few decades, the prevalence of allergic diseases,
such as atopic dermatitis, bronchial asthma allergic rhini-
tis, and food allergy (FA), has dramatically increased in
advanced countries. Since FA is relatively common in the
early stage of the “Allergy March”, in which symptoms are
exhibited successively with age, it is very important for
infants tooutgrow their FAfromaviewpoint of primary pre-
ventionofvariousallergydiseases[1,2].However,untilnow,
there have not been any eﬀective drug therapies for FA.
The intestinal epithelium is constantly exposed to a mul-
titude of foreign materials that are either harmful or benef-
icial for humans. Consequently, the intestinal immune sys-
tem must balance between protective immune responses that
are induced by encounters with intestinal pathogens and
tolerance against commensal bacteria and food antigens.
Despite the large extent of dietary antigenic exposure, the
intestinalmucosalimmunesystemhastheuniquepropensity
to evoke tolerance against orally administrated antigens and
thereby maintains optimal immunological homeostasis in
the intestine. It has been assumed that a breakdown in oral
tolerance mechanisms or a failure in the induction of oral
tolerance results in allergic food hypersensitivity [2–4].
Previous studies have shown that breast milk can inﬂu-
ence the incidence of allergic diseases in infants. Epidemio-
logicalstudiesontheprotectionfromallergicdiseasescaused
by breastfeeding have yielded conﬂicting results. Saarinen
and Kajosaari concluded from a prospective study in patients
up to 17 years old that the incidence of allergic diseases
was lower in the group of patients who were fed by breast
milk for a long period [5]. On the contrary, it has been
reported that complete breastfeeding for several months
postnatally cannot protect children against allergic diseases2 Clinical and Developmental Immunology
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Figure 1: Experimental protocol. Sensitized mice were exposed to 1% OVA in drinking water for 2 weeks immediately after delivery.
Oﬀspring were weaned at 4 weeks and 5-week-old oﬀspring were used for the FA model.
[6]. For many years, the American Academy of Pediatricians
and the United Kingdom government have recommended
maternal food antigen avoidance during pregnancy and
lactation to reduce FA. Actually, it is known that there are
suﬃcient concentrations of food antigens for making infants
develop FA [7]. However, until now, there have not been
any conclusive data that maternal food antigen restriction is
protective against FA in infants [8].
Furthermore, it remains controversial whether the
mother’s allergic status is a signiﬁcant risk factor for
the development of allergy in breastfed infants. In recent
prospectivestudiesonabirthcohortof3,115children,breast
feeding was demonstrated to be associated with a lower
asthma risk in children up to 8 years of age without evidence
of attenuation of the association and regardless of the child’s
family history of allergy [9].
I tr e m a i n su n c l e a rw h e t h e rm a t e r n a le x p o s u r et of o o d
antigens during lactation and maternal allergic status aﬀects
the development of allergic diseases in oﬀspring via transfer
of factors inﬂuencing susceptibility or resistance to allergic
diseases. Therefore, we investigated the ability of breast
milk from allergic mothers exposed to food antigens during
lactation to protect breastfed oﬀspring from FA.
2. Methods
2.1. Animals. BALB/c mice (Japan SLC, Shizuoka, Japan)
were used for the experiments and housed in the experi-
mental animal facility at University of Toyama. This study
was approved by the Animal Experiment Committee in
University of Toyama (Authorization No. is S-2009 INM-
9) in accordance with the Guide for the Care and Use
of Laboratory Animals in University of Toyama which is
accredited by the Ministry of Education, Culture, Sports,
Science, and Technology, Japan.
2.2. Experimental Protocols. To study the relationship
between breastfeeding and allergic diseases, 9-week-old
female BALB/c mice were sensitized twice at a 2-week
interval with 50μg of OVA in the presence of 1.3mg of
aluminum hydroxide gel by intraperitoneal injection. Non-
sensitized (vehicle-injected) and sensitized mice were mated
with na¨ ıve males 7 days after the ﬁrst intraperitoneal OVA
injection. Subsequently, lactating mice were exposed to 1%
OVA in drinking water for 2 weeks immediately after deliv-
ery (the duration of pregnancy in BALB/c mice is about 21
days). The oﬀspring were weaned at 4 weeks, and 5-week-old
oﬀspring were used to test our FA model (Figure 1). Brief,
BALB/c mice were sensitized twice at a 2-week interval
with 50μgo fO V Ai nt h ep r e s e n c eo f1 . 3m go fa l u m i n u m
hydroxide gel (Sigma-Aldrich), which served as an adjuvant,
by intraperitoneal injection. Two weeks after systemic prim-
ing, the mice were repeatedly given 50mg of OVA using
intragastric feeding needles three times per week. Allergic
diarrhea was assessed by visually monitoring mice up to 1
hour following intragastric OVA challenge. Mice with pro-
fuse liquid stool were recorded as allergic diarrhea-positive
animals. Tissues and plasma were obtained 1hour after the
seventh oral OVA challenge.
2.3. OVA-Speciﬁc Immunoglobulin Level in Plasma and Breast
Milk. OVA-speciﬁc IgE, IgA, and IgG1 levels in plasma as
well as OVA-speciﬁc IgA and IgG1 levels in breast milk were
measured by the sandwich ELISA method. The sensitive
sandwich ELISAs used to analyze OVA-speciﬁc IgE, IgA, and
IgG1 levels were developed using biotinylated rat anti-mouse
IgE (1:1,000; YAMASA, Tokyo, Japan), HRP-conjugated
sheep anti-mouse IgA (1:2,000; SouthernBiotech, Birm-
ingham, AL, USA), and HRP-conjugated sheep anti-mouse
IgG1 (1:2,000; SouthernBiotech). Plates were coated with
10μg/mL OVA (Fraction V; Sigma-Aldrich) at 4◦C overnightClinical and Developmental Immunology 3
and blocked with PBS containing 2% Block Ace (DS Pharma
Biomedical, Osaka, Japan). Diluted samples were added to
the plates, which were then incubated for 2 hour at 37◦C.
Each HRP-conjugated anti-immunoglobulin antibody was
added and the plates were then incubated for 1 hour at 37◦C.
Reactions were developed by 3,3 ,5,5 -tetramethylbenzidine
(Sigma-Aldrich), and color development was terminated by
0.5N HCl. Endpoint titers of OVA-speciﬁc immunoglobulin
antibodies were expressed as the reciprocal log2 of the last
dilution that showed a level of >0.1 absorbance over the
background levels, which gave an absorbance at 450nm.
Breast milk was collected from the stomachs of 7-day-old
neonatalmiceanddiluted10timeswithRPMI1640medium.
The diluted breast milk was centrifuged, and the supernatant
was collected as a breast milk sample.
2.4. Measurement of OVA Concentration in Breast Milk. OVA
levels in breast milk were analyzed using ITEA OVA ELISA
Kit (Precoated) (ITEA, Tokyo, Japan). Measurements were
performed according to the manufacturer’s instructions.
2.5. Expression of mRNA in the Intestine. mRNA expression
levels in the intestine were examined according to the
method previously described [10]. Brieﬂy, 1 hour after the
seventh oral OVA challenge, 2cm of the mouse proximal
colon was excised. Total RNA was extracted from the
proximal colon using Sepasol Super (Nacalai Tesque, Kyoto,
Japan) according to the manufacturer’s instruction. Reverse
transcription was performed using the ExScript RT reagent
Kit (Takara Bio, Shiga, Japan) and random primers, followed
by real-time PCR. Real-time PCR ampliﬁcation of IL-4, IFN-
γ,Foxp3,andGAPDHwasperformedusingSYBRPremixEx
Taq (Takara Bio). Target mRNA expression was normalized
to GAPDH mRNA expression as an internal control in each
sample. The results were expressed as the relative ratio to the
na¨ ıve group average.
2.6. Immunohistochemistry on Mucosal Mast Cells in the
Intestine. Immunohistochemistry was performed according
to the method previously described [10]. Brieﬂy, the excised
proximal colon was ﬁxed in 4% paraformaldehyde (w/v)
in 0.1M sodium phosphate buﬀer (PB, pH 7.3) at 4◦Cf o r
12–18 hour. Frozen sections (30μm) were cut at −20◦C
using a cryostat microtome (Leica Microsystems, Nussloch,
Germany).Thesectionswereexposedfor12–18hourtoanti-
serumagainstmousemastcellprotease-1(mMCP-1;amark-
er of mouse mucosal mast cells; 1:5000, Moredun Scientiﬁc,
Scotland, UK), washed with 0.01M PBS and incubated
for 2 hour with Cy3-conjugated sheep anti-donkey IgG
(1:200, Jackson Immunoresearch Laboratories, West Grove,
PA, USA). The immunostained sections were examined
using a ﬂuorescence microscope (IX71 System, Olympus,
Tokyo, Japan) with the ﬁlter set U-MWIG3 (Olympus) and
photographed using an Olympus digital camera (DP70,
Olympus). The brightness and contrast of the images
were modiﬁed with Adobe Photoshop Elements 2.0 (Adobe
Systems, San Jose, CA, USA).
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Figure 2: Eﬀects of the maternal exposure to food antigens during
lactation and the maternal allergic status on allergic symptoms in
FA model. OﬀspringbreastfedbyOVA-sensitizedandOVA-exposed
lactating mothers were more protected from the development of
allergic symptoms of FA compared with oﬀspring from OVA-
nonsensitized and OVA-exposed lactating mothers. Data are shown
as the means ± SE (8 independent experiments, total n = 62–181).
∗P<0.05, ∗∗P<0.01.
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Figure 3: Eﬀects of the maternal exposure to food antigens during
lactation and the maternal allergic status on plasma IgE levels
of oﬀspring in the mouse FA model. Plasma IgE levels were
undetectable in oﬀspring breastfed by OVA-sensitized and OVA-
exposed lactating mothers. Data are shown as the means and
individual data points. N.D.: not detectable. ∗∗P<0.01, n = 6–11.
2.7. Data Analyses. The data are expressed as the means
± S.E. or the means and dot plots. Statistical comparisons
were made using two-tailed Student’s unpaired t-tests or
one-way ANOVA followed by Tukey’s post-hoc test for
multiple comparisons of data with a normal distribution
or Games-Howell test for multiple comparisons of data
with a nonnormal distribution. P values less than 0.05 were
considered to be statistically signiﬁcant.4 Clinical and Developmental Immunology
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Figure 4: Eﬀects of the maternal exposure to food antigens during lactation and the maternal allergic status on Th1 and Th2 cytokine
proﬁles in the proximal colons of oﬀspring with FA. The mRNA expression levels of IL-4 were completely reduced to the na¨ ıve mice range in
oﬀspring breastfed by OVA-exposed mothers during lactation, but IFN-γ mRNA expression levels were not altered by the maternal exposure
to food antigens and the maternal allergic status. Data are shown as the means and individual data points. ∗P<0.05, ∗∗P<0.01, n = 5–10.
3. Results
3.1. Breast Milk from OVA-Exposed Allergic Mothers during
Lactation Protects Oﬀspring from Allergic Symptoms in Food
Allergy Model. Oﬀspring breastfed by OVA-nonsensitized
and OVA-unexposed mothers developed the symptoms
of FA (Figure 2: Control group: 97.1 ± 1.9% after the
seventh oral OVA challenge). We next determined whether
maternal exposure to 1% OVA in drinking water during
lactation aﬀectsintestinal allergic symptoms in oﬀspring. We
found that about half of the oﬀspring breastfed by OVA-
nonsensitized and OVA-exposed mothers exhibited allergic
reactionsaftertheseventhOVAchallenge(Figure 2:Ogroup;
59.7 ± 13.2% after the seventh oral OVA challenge, P<
0.05 compared with the control group). Furthermore, when
compared with the O group oﬀspring, a reduction in allergic
symptomswasevidentinoﬀspringnursedbyOVA-sensitized
and OVA-exposed mothers (Figure 2: S + O group; 24.6
± 8.8% after the seventh oral OVA challenge, P<0.05
compared with the O group), although breast milk from
OVA-sensitizedandOVA-unexposedmothershadlittleeﬀect
on the development of FA in oﬀspring (Figure 2:Sg r o u p :
89.7 ± 4.4% after the seventh oral OVA challenge).
Plasma levels of OVA-speciﬁc IgE was very high in the
control group oﬀspring (Figure 3). OVA-speciﬁc IgE in S +
Og r o u po ﬀspring were virtually undetectable (Figure 3: P<
0.01 compared with the control group), while S group oﬀ-
spring exhibited high OVA-speciﬁc IgE levels compara-
ble with the control group oﬀspring (Figure 3). Although
OVA-speciﬁc IgE levels in O group oﬀspring tended to be
lower compared with those in the control group oﬀspring,
there were large individual diﬀerences among the O group
oﬀspring (Figure 3).
3.2. Maternal Exposure to OVA during Lactation Suppresses
the Th2-Polarized Cytokine Proﬁle in the Proximal Colons of
Oﬀspring with Food Allergy. We examined Th1 (IFN-γ)a n d
Th2 (IL-4) cytokine proﬁles in the proximal colons of the
oﬀspringineachofthefourgroups.IFN-γ mRNAexpression
in the proximal colon was not enhanced in the FA model
mice and not aﬀected by the maternal exposure to OVA
during lactation and/or the maternal allergic status.
Conversely, IL-4 mRNA expression was greatly upregu-
lated in the proximal colons of the control group oﬀspring
(Figure 4: P<0.01, 556.4 ± 102.6 compared with na¨ ıve
mice: 1.0 ± 0.2), and the maternal exposure to OVA
during lactation markedly prevented the enhancement of IL-
4 mRNA expression in the proximal colons of both the O
group and S + O group oﬀspring (Figure 4: P<0.01, 16.4 ±
4.8 and 30.6 ± 14.2, respectively, compared with the control
group oﬀspring). The S group oﬀspring exhibited high levels
of IL-4 mRNA expression that were comparable to those of
the control group oﬀspring (Figure 4: 402.3 ± 116.1).
3.3. Maternal Exposure to OVA during Lactation Prevents
Mucosal Mast Cell Inﬁltration in the Proximal Colons of
Oﬀspring with Food Allergy. Mucosal mast cells were dra-
matically increased in the proximal colons of the controlClinical and Developmental Immunology 5
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Figure 5: Eﬀects of the maternal exposure to food antigens during lactation and the maternal allergic status on mucosal mast cell inﬁltration
in the proximal colons of oﬀspring FA. The inﬁltration of mucosal mast cells was greatly attenuated in oﬀspring with FA breastfed by OVA-
exposed mothers during lactation.
group oﬀspring, while they were markedly decreased in the
proximal colons of both the O group and S + O group
oﬀspring. Many mucosal mast cells were observed in the
proximal colons of the S group oﬀspring, and these levels
were comparable to those in the proximal colons of the
control group oﬀspring (Figure 5).
3.4. Maternal Transfer of OVA and/or OVA-Speciﬁc Antibodies
Through Breast Milk. Next, we determined whether the
allergicsymptomsinoﬀspringwereassociatedwithmaternal
transfer of OVA and/or OVA-speciﬁc antibodies (IgG1 and
IgA) through breast milk. Among the mothers of the four
groups, OVA was only detected in the breast milk of mothers
from the O group (4.6 ± 0.5μg/mL, n = 5). Although OVA-
speciﬁc IgG1 were not detected in the breast milk from the
controlandOgroupmothers,thesensitizationofmothersto
OVAincreasedtheconcentrationofOVA-speciﬁcIgG1inthe
breastmilkoftheS+Ogroupmothers(Sgroupmother:11.0
± 0.5, S + O group mother: 12.3 ± 0.3; Figure 6, P<0.01, n
= 5). In contrast, OVA-speciﬁc IgA was detected only in the
breast milk from the S + O group mothers (Figure 6, n = 5–
9).
We further analyzed plasma OVA-speciﬁc IgG1 and IgA
levels in 7-days-old oﬀspring of the four groups to elucidate
the transfer of OVA-speciﬁc IgG1 and IgA from mothers to
oﬀspring via breast milk. Similarly to OVA-speciﬁc IgG1 in
the breast milk, plasma OVA-speciﬁc IgG1 was detected in
both the S group and S + O group oﬀspring but not in the
control group and O group oﬀspring (Figure 7). Conversely,6 Clinical and Developmental Immunology
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Figure 6: Eﬀects of the maternal exposure to food antigens during lactation and the maternal allergic status on OVA-speciﬁc IgG1 and IgA
levels in breast milk. We found OVA-speciﬁc IgG1 only in the breast milk from OVA-sensitized mothers, which implies that mother mice
secrete IgG1intotheir breast milk.We foundOVA-speciﬁcIgA onlyinthebreast milkfromOVA-sensitizedandOVA-exposed mothers.Data
are shown as the means and individual data points. N.D.: not detectable. ∗P<0.05, ∗∗P<0.01, n = 5–9.
plasmaOVA-speciﬁcIgAwasundetectableintheoﬀspringof
all four groups (Figure 7).
4. Discussion
This study was performed to test our hypothesis that
maternal factors transferred through breast milk aﬀect the
development of FA in oﬀspring. In the present study, using
a mouse FA model, we demonstrated that the induction
of oral tolerance can suppress food allergic symptoms and
that maternal ingestion of food antigens during lactation,
especially in allergic mothers, can induce eﬀective oral
tolerance, thereby preventing the onset of FA.
4.1. Induction of Oral Tolerance. Early tolerance induction
is an attractive approach for primary prevention of allergic
diseases. Recently, the preventive eﬀects of oral tolerance on
allergic diseases such as allergic asthma and allergic rhinitis
have been reported in experimental models [11–13].
Experimental FA models where repeated oral challenges
with OVA in systemically OVA-primed BALB/c mice led
to allergic diarrhea require aberrant Th2-type responses,
such as an enhanced production of IL-4, IL-5, and IL-
13 by the spleen and large intestine and high levels
of OVA-speciﬁc plasma IgE [14, 15]. We have reported
that phosphatidylinositol-3 kinase deﬁcient mice (BALB/c
background) selectively lacking gastrointestinal mast cells
could not develop allergic diarrhea in our FA model [16],
suggesting that mucosal mast cells in the intestine play an
important role in the pathogenesis and development of
allergic diarrhea.
In 2011, Hadis et al. have demonstrated that the induc-
tion of oral tolerance prevents food allergic diarrhea in adult
mice [17]. Here we also show that oral tolerance induced
by the exposure to OVA prevents the increase in plasma
OVA-speciﬁc IgE levels and Th2 cytokine mRNA expression
in both systemic and mucosal immune system, in addition,
the exposure to OVA abrogates the augmentation of the
inﬁltration of mucosal mast cells into the colon (see sup-
plemental materials available at doi:10.1155/2012/721085,
Supplemental Figures 1–5).
4.2. Inﬂuence of the Maternal Exposure to Food Antigens dur-
ing Lactation on Allergic Symptoms. Interestingly, Verhasselt
et al. demonstrated that breast-milk-mediated transfer of
antigens to the neonate results in oral tolerance induction
leading to antigen-speciﬁc protection from allergic airway
disease in a mouse experimental model [18]. However,
it remains controversial in humans whether food antigen
ingestion by the lactating mother aﬀects the development
of FA in neonates. Thus, in the current study, we addressed
this issue with our mouse FA model. We found that breast-
feeding by OVA-nonsensitized and OVA-exposed mothers
moderately reduced the incidence of allergic symptoms in
neonates, and food antigen OVA was detected in breast milk
only from OVA-nonsensitized and OVA-exposed mothers
during lactation, indicating that the prior neonatal exposure
to the low levels of food antigens within the breast milkClinical and Developmental Immunology 7
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Figure 7: Eﬀects of the maternal exposure to food antigens during lactation and the maternal allergic status on plasma OVA-speciﬁc IgG1
and IgA levels in oﬀspring. We found OVA-speciﬁc IgG1 only in the plasma of na¨ ıve oﬀspring breastfed by OVA-sensitized mothers, which
implies that OVA-speciﬁc IgG1 transferred from mothers circulate in their oﬀspring. Plasma OVA-speciﬁc IgA levels were undetectable in
the four groups of oﬀspring. Data are shown as the means and individual data points. N.D.: not detectable. ∗P<0.05, ∗∗P<0.01, n = 5–7.
from these mothers for 2 weeks moderately alleviates the
susceptibility of their neonates to FA. Furthermore, our
results indicate that OVA transferred through breast milk
from OVA-exposed mothers during lactation induces oral
tolerance, which suppresses the increases in plasma OVA-
speciﬁc IgE levels and Th2 cytokine mRNA expression levels
in the mucosal immune system and the augmentation of
the inﬁltration of mucosal mast cells into the colon, thereby
alleviating the development of FA. Food antigens ingested
by mothers during lactation are also secreted into breast
milk in humans [7, 19]. Taken together, the present results
led us to propose the hypothesis that induction of oral
tolerance by the maternal ingestion of food antigens during
lactation is a strategy for the prevention of FA in infants.
However, breast milk from OVA-nonsensitized and OVA-
exposed mothers during lactation protects only about half of
the oﬀspring from allergic symptoms and drastic increases in
plasma OVA-speciﬁc IgE levels, implying that the induction
of oral tolerance simply by the maternal exposure to OVA
during lactation is not suﬃcient for the prevention of FA in
oﬀspring.
4.3. Inﬂuence of the Mother’s Allergic Status on the Susceptibil-
ity of Oﬀspring to Food Allergy. Mosconi et al. demonstrated
that breastfeeding by antigen-exposed sensitized mothers
abolishes asthma development in progeny. Compared with
the protection elicited by antigen-exposed nonsensitized
mothers, protection by sensitized mothers was much more
profound [20]. Furthermore, L´ opez-Exp´ osito et al. showed
that low-dose food antigen exposure during pregnancy and
lactation reduces the risk of oﬀspring developing ﬁrst-ex-
posure food antigen-induced anaphylaxis and speciﬁc IgE
production to active food antigen sensitization in oﬀspring
in a mouse peanut FA model [21]. In the present study, we
showed that oﬀspring breastfed by OVA-sensitized and OVA-
exposed mothers were dramatically protected from the de-
velopment of FA. Furthermore, OVA-speciﬁc IgA and IgG1
were detected in the breast milk from these mothers. In con-
trast, breast milk from OVA-sensitized and OVA-unexposed
mothers had little eﬀect on the development of FA in oﬀ-
spring.
It is known that antigen-speciﬁc IgA and IgG form
immune complexes with antigens in breast milk [20, 22, 23].
Therefore, it is assumed that OVA that has been ingested by
allergic mothers during lactation and then secreted into their
breast milk immediately forms immunity complexes with
maternal OVA-speciﬁc immunoglobulins, thereby masking
epitopes of OVA detected by OVA-speciﬁc antibodies of OVA
ELISA Kit. Thus, we could not measure OVA in the breast8 Clinical and Developmental Immunology
milk from OVA-sensitized and OVA-exposed mothers using
OVA ELISA kit, while we could detect OVA in breast milk
from OVA-nonsensitized and OVA-exposed mothers. It has
been reported that an antigen-IgA immune complexes are
eﬃcientlytakenupbythebodybytranscytosisasanimmune
complex through speciﬁc receptors on M cells [24–26].
Moreover,theneonatalFcreceptorforIgG(FcRn),which
is the IgG receptor that is expressed on intestinal epithelial
cells, is known to contribute to the absorption of IgG and
antigen-IgG immune complexes within breast milk [27–
29]. Mosconi et al. demonstrated that milk-borne OVA-IgG
complexes are actively transferred from mothers to oﬀspring
by the FcRn. Furthermore, FcRn-mediated transfer of OVA-
IgG complexes resulted in the induction of FoxP3+ regu-
latory T cells in mesenteric lymph node and that FcRn-
deﬁcient mice breastfed by OVA-exposed allergic mice were
not protected from allergic airway disease [20]. In this study,
we showed that OVA-speciﬁc IgG1 was detected in breast
milk from allergic mothers, and OVA-speciﬁc IgG1 was also
detected in the plasma of their oﬀspring, while OVA-speciﬁc
IgA was not detected in plasma of any oﬀspring. Taken
together, these data imply that OVA is eﬀectively transferred
into oﬀspring via immune complexes of OVA and OVA
speciﬁc IgG1 in breast milk through FcRn in comparison to
OVA alone in breast milk and thereby eﬀectively induces oral
tolerance to protect neonates from FA.
5. Conclusions
Our results indicate that oral tolerance induced by breast-
milk-mediatedtransferoffoodantigensbyspeciﬁcimmuno-
globulins to oﬀspring leads to antigen-speciﬁc protection
fromFA.Ourﬁndingsmaypavethewayforthedevelopment
of novel approaches to primary prevention of allergic dis-
eases such as FA. Furthermore, pioneering researches should
be undertaken to target the treatment with immune com-
plexes of food antigen and food antigen-speciﬁc IgG1 for the
eﬀective prevention strategies against FA.
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